Guangzhou, China

Jufu Zhang

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Guangzhou Henovcom Bioscience Co. Ltd. Active years: 2023-2024.


% Patents Active = 100.0

 

 

Average Co-Inventor Count = 9.5

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jufu Zhang: Innovator in Genetic Engineering

Introduction

Jufu Zhang is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of genetic engineering, particularly through his innovative patents. With a total of 2 patents, Zhang's work focuses on advancing the understanding and application of RNA capping and pharmaceutical compositions.

Latest Patents

Zhang's latest patents include "Compounds for RNA capping and uses thereof." This patent relates to compounds that enhance RNA capping efficiency, resulting in capped mRNA with high transcription levels and increased expression. Another notable patent is for an "Aromatic heterocyclic compound, and pharmaceutical composition and use thereof." This invention presents a novel heteroaromatic compound that acts as an Autotaxin inhibitor, offering potential treatments for diseases characterized by Autotaxin overexpression in mammals.

Career Highlights

Jufu Zhang is associated with Guangzhou Henovcom Bioscience Co. Ltd., where he continues to push the boundaries of genetic research. His work has garnered attention for its potential applications in therapeutic settings, showcasing his commitment to innovation in biotechnology.

Collaborations

Zhang collaborates with esteemed colleagues, including Jiancun Zhang and Lijun Zhang, who contribute to his research endeavors. Their combined expertise enhances the impact of their work in the scientific community.

Conclusion

Jufu Zhang's contributions to genetic engineering through his patents reflect his dedication to advancing medical science. His innovative approaches hold promise for future developments in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…